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a b s t r a c t
RNA interference (RNAi), the sequence-speciﬁc suppression of gene expression, offers great opportunities
for insect science, especially to analyze gene function, manage pest populations, and reduce disease
pathogens. The accumulating body of literature on insect RNAi has revealed that the efﬁciency of RNAi
varies between different species, the mode of RNAi delivery, and the genes being targeted. There is also
variation in the duration of transcript suppression. At present, we have a limited capacity to predict the
ideal experimental strategy for RNAi of a particular gene/insect because of our incomplete understanding
of whether and how the RNAi signal is ampliﬁed and spread among insect cells. Consequently, development of the optimal RNAi protocols is a highly empirical process. This limitation can be relieved by systematic analysis of the molecular physiological basis of RNAi mechanisms in insects. An enhanced
conceptual understanding of RNAi function in insects will facilitate the application of RNAi for dissection
of gene function, and to fast-track the application of RNAi to both control pests and develop effective
methods to protect beneﬁcial insects and non-insect arthropods, particularly the honey bee (Apis mellifera) and cultured Paciﬁc white shrimp (Litopenaeus vannamei) from viral and parasitic diseases.
Ó 2013 Elsevier Ltd. All rights reserved.
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and discuss the unique opportunities and challenges associated
with each of these applications.

1. Introduction
RNA interference (RNAi) has transformed insect science research because it enables the researcher to suppress a gene of
interest and thereby link a phenotype to gene function. For basic
research purposes, RNAi offers a route to functional genetics in
all insects, including those for which transgene resources do not
exist (Belles, 2010). RNAi also has enormous potential for applied
entomology (Price and Gatehouse, 2008; Xue et al., 2012). For
example, RNAi can be used for insect pest control by suppressing
essential genes leading to reduced ﬁtness and/or mortality. Furthermore, by priming the antiviral RNAi response with innocuous
viral sequences, beneﬁcial insect species, such as honey bee (Apis
mellifera) and silkworm (Bombyx mori), can be protected from
highly pathogenic viral infections. However, the reality is not yet
matching the envisioned potential of RNAi. Practitioners are
increasingly aware that RNAi in insects can be capricious; efﬁcacy
varies across insect taxa, among genes, with mode of delivery, and
even between different laboratories (Terenius et al., 2011). All too
often, the application of RNAi technology is an empirical exercise:
‘‘try it, for it might work’’.
The goal of this article is to promote the use of practical principles to design and interpret insect RNAi studies. We know that no
single protocol can be applied for every gene in every insect. Therefore, the speciﬁc purpose of this article is to provide a roadmap for
the application of RNAi for experimental analysis of gene function,
management of pests and protection of beneﬁcial arthropods. The
article is divided into three sections. First, current knowledge of
the mechanisms and function of RNAi in insects is reviewed, highlighting the known variation among insect taxa. This information
offers a guide to the most appropriate strategy for different insect
systems, and provides the springboard for much-needed future
innovation in RNAi technology. Second, the design of RNAi studies
is addressed, using both empirical data and conceptual understanding to identify successful experimental designs, effective
methods for RNAi delivery, and informative indices of RNAi efﬁcacy. Importantly, there is no single protocol for the perfect RNAi
experiment, partly because the efﬁcacy of RNAi strategies varies
among insect groups. In the third section, we turn to the application of RNAi for the management of pest and beneﬁcial insects,

2. Mechanisms of RNAi
RNAi refers to the suppression of gene expression by small noncoding RNA molecules, predominantly by the cleavage of a target
mRNA in a sequence-speciﬁc manner (Fire et al., 1998), and the
general steps involved in this process are shown in Fig. 1. Upon cell
entry and recognition, double stranded RNA (dsRNA) is cleaved by
the RNase III Dicer into 20–25 bp fragments with a two base overhang at the 30 end. These fragments are incorporated into the multi-protein RNA-induced silencing complex (RISC), where one
strand (the ‘‘passenger’’ strand) is eliminated and the other ‘‘guide’’
strand is retained. The catalytic component of RISC is the RNase
H-like domain of an Argonaute protein, which cleaves singlestranded RNA molecules having sequence complementary to the
guide RNA. Most eukaryotes, including animals and plants, have
Dicer and Argonaute proteins, and possess the RNAi machinery
(Shabalina and Koonin, 2008).
The 20–25 bp RNAs generated by Dicer comprise two groups
(Ghildiyal and Zamore, 2009; Matranga and Zamore, 2007; Asgari,
2013): microRNAs (miRNAs), which are processed from endogenous gene transcripts and function in the regulation of gene
expression, and small interfering RNAs (siRNAs), which are derived
from dsRNA molecules and provide defense against viruses and
transposable elements. The experimental use of RNAi exploits the
siRNA pathway, speciﬁcally the capacity of cells to degrade a single-stranded RNA (ssRNA) (including mRNAs) with sequence identity to the administered dsRNA molecules.
Three processes determine what can be achieved by RNAi:
cellular uptake of the RNAi molecule (usually dsRNA), the production of secondary dsRNA molecules in the cell, and the transfer of
these molecules to other cells (Fig. 1). Where the RNAi–mediated
silencing is transmitted widely throughout the treated organism,
RNAi is described as systemic (Whangbo and Hunter, 2008;
Huvenne and Smagghe, 2010). In principle, the success of an RNAi
experiment could be predicted from the level of these activities in
the insect of interest, and strategies that increase these activities

dsRNA Uptake
Promoted by dsRNA specific
channel and/or endocytosis
May be limited by dsRNases in
digestive tract and hemolymph

Among-Cell Spread
of Silencing
Via dsRNA or siRNA
Unknown route of export from
cells

RNAi Machinery
Core enzymes (Dicer &
Argonaute) present in
insects
Core enzyme abundance
may limit RNAi efficiency
in some insects

Within-Cell Amplification
of Silencing
RNA-dependent RNA polymerase
apparently absent
Incidence of amplification &
possible mechanisms not known

Molecular & Phenotypic
Consequences
Quantify as suppression of
target transcript and protein
Identify expected phenotype in
experimental design

Fig. 1. The RNAi process in insects. See text for additional details
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might enhance RNAi-mediated knockdown of the target gene
expression. The difﬁculty is that we have little or no understanding
of whether or how dsRNAs are ampliﬁed within insect cells or
disseminated among insect cells.
In C. elegans, systemic spread of RNAi is optimal for dsRNA molecules >50 bp long, and is independent of Argonaute function
(Feinberg and Hunter, 2003; Tabara et al., 1999), suggesting that
the molecules moving between cells are dsRNAs, and not ampliﬁed
siRNA. Uptake of dsRNA by somatic cells requires the protein SID-1
(systemic interference defective-1), which is inferred to function as
a dsRNA channel (Winston et al., 2002). Other C. elegans proteins,
SID-2 and SID-5, have been implicated in dsRNA uptake by gut cells
and dsRNA export from cells, respectively (Hinas et al., 2012; Winston et al., 2007). Putative insect orthologs of the C. elegans sid
genes have been described (e.g. Dong and Friedrich, 2005; Xu
and Han, 2008), but these reports deserve careful evaluation. The
sid-1-like genes in various insects have a greater sequence identity
with the C. elegans gene chup-1, also known as tag-130, than to
sid-1. CHUP-1 is a cholesterol transporter and has no known
involvement in RNAi (Valdes et al., 2012). As an illustration, a gene
in Locusta migratoria initially identiﬁed as sid-1-like is not required
for systemic RNAi (Luo et al., 2012), and is the ortholog of C. elegans
CHUP-1 (as determined by top reciprocal BLASTp hit), and not
SID-1.
Plants and the nematode Caenorhabditis elegans possess an
RNA-dependent RNA polymerase (RdRP) (Pak and Fire, 2007; Xie
et al., 2001) that facilitates the within cell ampliﬁcation of silencing. The fragments of the target ssRNA released from the RISC act
as a template for RdRP-dependent dsRNA synthesis, yielding more
substrate for RISC-mediated degradation of the target ssRNA. Efﬁcient ampliﬁcation of RNAi by RdRP can drive the abundance of the
target ssRNA molecule to undetectable levels, and RdRP is essential
for RNAi in C. elegans (Sijen et al., 2001). RdRP has been identiﬁed
in a few animal species beyond Caenorhabditis nematodes, including the cephalochordate Branchiostoma ﬂoridae (Vienne et al.,
2003), but no veriﬁed RdRP homolog is evident in any insect genome sequenced to date (Tomoyasu et al., 2008). It is unclear
whether or how the RNAi triggered by the acquisition of dsRNA
molecules is sustained in insect cells (Fig. 1).
Analysis of gene orthology between C. elegans and insects has
been a productive approach to identify the core RNAi machinery
in insects, but far less informative for understanding the molecular
basis of intracellular ampliﬁcation and systemic spread of RNAi.
The alternative discovery-based strategy of a genetic screen, using
rescue from RNAi-lethality, has great potential. For example, Ulvila
et al. (2006) demonstrated that uptake of dsRNA by Drosophila S2
cells is strongly endocytosis-dependent, and mediated principally
by the scavenger receptors Eater and SR-CI. We should, however,
be cautious in extrapolating from these data to organismal RNAi
because S2 cells, which are hemocyte-like, display high rates of
endocytosis as compared to the majority of cell types in the intact
insect.
The physiological role of insect RNAi could be informative in
predicting RNAi efﬁcacy in different insect taxa and cell types
and, by extension, the development of sustainable strategies for
RNAi applications in ﬁeld conditions. There is a strong consensus
that RNAi contributes to insect immunity against viruses with a
dsRNA genome or dsRNA replicative intermediates in the cytoplasm of infected cells (Blair, 2011; Schnettler et al., 2012). We
could, therefore, expect greatest success with RNAi in insect species and cell types that utilize RNAi as a primary anti-viral immune
response. Some insects or cell types may have low responsiveness
to exogenously-applied dsRNA because they utilize alternative
anti-viral defenses (e.g. apoptosis of infected cells, symbiont-mediated protection) (Merkling and van Rij, 2013). It should also be
noted that certain insect viruses suppress RNAi. For example, ﬂock

Fig. 2. Current methodologies for RNAi delivery in insects: a guide on the
performance of different delivery methods. All approaches yield transient RNAi
other than the transgenic method. ? = lack of data prevents evaluation. RNAi
efﬁcacy in Drosophila is limited to hemocytes if delivered by injection (Miller et al.,
2008). Delivery by feeding can be highly effective (Whyard et al., 2009), but
transgenesis is the preferred methodology. In Aedes aegypti, RNAi has been most
successful by injection (e.g. Campbell et al., 2008), transgenesis (e.g. Bian et al.,
2005), and viral transduction (e.g. Adelman et al., 2001), with a few reported
instances of success by feeding (Coy et al., 2012; Mysore et al., 2013) or topical
application (Pridgeon et al., 2008). Most cases of successful RNAi in Tribolium
castaneum have been by injection (e.g. Arakane et al., 2005). RNAi efﬁcacy in
Manduca sexta is most effective by injection for immune-related genes, and there is
evidence to support successful gene suppression by delivery by feeding (Terenius
et al., 2011). RNAi in A. pisum has been successful by both injection (Mutti et al.,
2006) and feeding (Shakesby et al., 2009). RNAi in Apis mellifera is effective for a
variety of genes and life stages both by injection and feeding (Amdam et al., 2003;
Hunter et al., 2010). Even where a speciﬁc method of application has shown success
for RNAi of certain genes, the effective suppression of all genes by that technique is
not guaranteed.

house virus (FHV) codes for a protein, known as the B2 protein,
that binds to dsRNA, including the FHV replication intermediate,
preventing cleavage by insect Dicer and incorporation into RISC
(Chao et al., 2005). An insect infected with an asymptomatic, persistent virus that codes for an RNAi suppressor would display limited responsiveness to experimental RNAi (Berry et al., 2009).

3. Designing a RNAi experiment
As described above, RNAi application and efﬁcacy remains variable between genes, organisms and life stages, despite the tremendous utility that RNAi presents for improving our
understanding of fundamental biological questions and for pest
control. In addition, in insect species where RNAi is predominantly
environmental with little evidence for systemic propagation, interference can vary widely between tissues due to differences in the
efﬁcacy of dsRNA uptake. Extreme examples are D. melanogaster
and Manduca sexta where transcript knockdown by injection of
dsRNA has only been achieved in hemocytes, which are capable
of endocytosis (Miller et al., 2008; Terenius et al., 2011). In mosquitoes, most tissues can be reached by the injection of dsRNA, however the success of knockdown in the central nervous system
varies highly between genes and may be dose-dependent (Lycett
et al., 2006; Biessmann et al., 2010). Tissue differences in RNAi efﬁcacy may be overcome by the design of new delivery methods,
including transgenesis or viral transduction, which eliminate the
requirement for cellular uptake of the RNAi trigger. Development
of such technologies is lacking for the majority of species (Fig. 2
and Section 3.2 below).
The aforementioned biological variables, including presence/absence of the core RNAi machinery, cellular uptake and propagation
of signal (Roignant et al., 2003; Miller et al., 2008), and dsRNA
degrading enzymes (Arimatsu et al., 2007), as well as other differences in genetic backgrounds (Kitzmann et al., 2013), greatly affect
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the success of RNAi experiments in different species. Often, these
challenges can be mitigated by experimental factors including
the design of the RNAi molecule, the mode of delivery and the dose
of the dsRNA molecule.
3.1. The RNAi molecule
The success of an RNAi experiment hinges on the production of
a speciﬁc RNAi molecule (in the form of dsRNA, siRNA, or a hairpin
RNA) for a target gene of interest (GOI). Experiments should include an RNAi molecule against a heterologous sequence absent
from the target insect’s genome (typically green ﬂuorescent protein (GFP) or LacZ), to control for both the administration of the
experimental dsRNA and the physiological impact of triggering
the RNAi cascade. In some cases, a positive control can be incorporated into the experimental design. For example, in Tribolium, the
use of RNAi against vermillion (white) or Lac-2 provides rapid phenotypic evidence of RNAi success manifest in white compound
eyes or white pupae, respectively (Arakane et al., 2005, 2011).
A crucial consideration is the choice of sequence for dsRNA
preparation, especially its length and sequence identity to the target transcript of the insect. Huvenne and Smagghe (2010) provide a
comprehensive survey of the length range of dsRNAs used in early
studies: from 134 to 1842 bp, with most studies using 300-520 bp.
Comparisons among gene regions (e.g., 5’ end) to which RNAi molecules are designed have yielded variable results. For example,
RNAi against hunchback (hb) in Acyrthosiphon pisum resulted in
similar mortality whether the RNAi trigger was designed against
the 50 or 30 end of the gene (Mao and Zeng 2012), but the 30 portion
of the inhibitor of apoptosis gene in Aedes aegypti yielded a greater
effect on mosquito mortality than dsRNA targeting the 50 or central
region of the gene (Pridgeon et al., 2008), and the most effective
antiviral RNAi molecule against infectious myonecrosis virus
(which infects the Paciﬁc white shrimp, Litopenaeus vannamei)
was at the extreme 50 end of the genome (Loy et al., 2012). These
varied results illustrate the importance of screening multiple RNAi
sequences for a gene of interest.
Generally speaking, greater success with insect RNAi has been
obtained with dsRNA molecules >50–200 bp in length (Huvenne
and Smagghe, 2010), although the minimal length required to obtain maximal biological activity varies among insect species
(Bolognesi et al., 2012). Suppression of gene expression has been
achieved with siRNAs (either synthesized directly or obtained by
‘‘dicing’’ the dsRNA in vitro before administration to the insect),
for example in the lepidopteran Helicoverpa armigera (Kumar
et al., 2012), aphid A. pisum (Mutti et al., 2006) and tsetse (Attardo
et al., 2012). It may, sometimes, be necessary to design the RNAi
molecule of shorter length than ideal to obtain speciﬁcity, especially where one member in a gene family that has high sequence
similarity is being targeted. Regardless of the desired size of the
RNAi molecule, the design process can be aided by software that
is informed by genome sequence and RNA folding kinetics to optimize effectiveness; for example, E-RNAi currently offers dsRNA
and siRNA design suggestions for A. mellifera, Tribolium castaneum,
A. pisum, Anopheles gambiae and Ae. aegypti (Horn and Boutros,
2010).
A further issue to be considered in the design of RNAi molecules
is the exquisite speciﬁcity of RNAi. In the context of ﬁeld applications of RNAi, this property facilitates design of insect-lethal sequences that are highly species-speciﬁc. For example, feeding four
species of Drosophila with species-speciﬁc vATPase dsRNA resulted
in reduced vATPase mRNA and signiﬁcant mortality in conspeciﬁc,
but not heterospeciﬁc ﬂies (Whyard et al., 2009). In basic research
pursuits, this property affords researchers the capacity to silence
alleles (using short dsRNA) of the same gene speciﬁcally, e.g. TEP1
alleles in An. gambiae (Blandin et al., 2009). Conversely, two alleles
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of a heterozygous individual, as well as genetically-distinct members within an insect population, whether in the laboratory or ﬁeld,
may differ in their susceptibility to RNAi. This concern is amply justiﬁed by studies on the effect of mismatches between the dsRNA
and its intended target (i.e. mRNA) using synthetic siRNAs administered to mammalian cells in culture. Most single mismatches
impair the RNAi effect (Birmingham et al., 2006; Jackson et al.,
2003; Joseph and Osman, 2012a,b; Wu et al., 2011); some mismatches, however, alter the cellular response from one of transcript
loss (siRNA) to translational repression, (Hu et al., 2010; Tomari
et al., 2007). The advantages of using longer >200 bp dsRNA for
RNAi strategies in pest management is the production of many
siRNAs against the targeted mRNA transcript; potentially maximizing the RNAi response. Further studies will be necessary to clarify
the extent to which the responses to mismatches in dsRNA and
target mRNA in whole insects differ from the siRNA studies which
used a single construct conducted on cultured mammalian cells.
3.2. RNAi delivery
Efﬁcacy of an RNAi experiment can be inﬂuenced strongly by
the mode of delivery of the RNAi trigger (Fig. 2 and references
within). The most widely used routes for administering RNAi to insects are injection into the hemolymph and feeding. Microinjection
was used in the ﬁrst successful application of RNAi in an insect, to
obtain knockdown of frizzled in Drosophila melanogaster (Kennerdell and Carthew, 1998). This method was quickly transferred to
T. castaneum (Brown et al., 1999) and subsequently applied to adult
insects in An. gambiae (Blandin et al., 2002). Microinjection has
been applied to all life stages in hemi- and holometabolous insects
in a rapidly growing number of orders; indeed routine protocols
are now in place for injection for various taxa, including Tribolium,
B. mori, several genera of Diptera, the honey bee, cockroaches and
orthopterans [for a list of references, see Belles (2010)].
An important barrier to the use of microinjection in some insects is non-speciﬁc damage caused by mechanical damage, which
is most often pronounced when targeting embryos. Experimental
variables that inﬂuence survivorship include methods of immobilization (cold, CO2, adherence to a substrate), injection volume, site
of injection, and dilutants. Although water or physiologic saline
work well for most species, the diluent may require adjustment
to the particular osmotic pressure of the hemolymph.
Oral delivery is a less-invasive and potentially a high-throughput method for RNAi delivery. It has particular value for insects
that are intolerant of injection (Fig. 2) and for ﬁeld applications
for RNAi-mediated pest control (see Section 4). Protocols for
administration of dsRNA synthesized in vitro and incorporated into
the diet are now available for honey bees, aphids, whiteﬂies and
psyllids (Aronstein et al., 2006; Wuriyanghan et al., 2011; Ghanim
et al., 2007; Whyard et al., 2009). RNAi delivery to phytophagous
insects can also be achieved by engineering plants to express
dsRNAs in plant systems for which transgene introduction technologies are available (Fig. 2). Two complementary methods are in
use: stable transformation by hairpin dsRNAs that target insect
genes (Baum et al., 2007) and transient virus-induced gene silencing (VIGS), in which engineered viral vectors carrying the gene sequence of interest are transformed into Agrobacterium tumefaciens
and inﬁltrated into the plant tissue (Burch-Smith et al., 2004). Both
approaches have been exploited, to achieve transcript suppression
in Coleoptera (Baum et al., 2007), Lepidoptera (Baum et al., 2007;
Kumar et al., 2012) and Hemiptera (Pitino et al. 2011; Zha et al.,
2011). In some species, notably dipterans, oral delivery of RNAi
triggers has yielded less consistent results than microinjection
(Zhang et al., 2010). Further, in Lepidoptera, feeding as a mode of
delivery necessitates the provision of high doses of RNAi trigger
(Terenius et al., 2011). This can be attributed to a variety of factors.
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The efﬁcacy of RNAi of midgut transcripts may be reduced due to
low or inconsistent doses taken up by individual insects, frequency
and size of feeding, plus GI tract morphology and physiology will
affect the actual dose of RNAi that reaches the midgut epithelium.
In addition, there is evidence for production of mRNAs that encode
putative secretory dsRNA-degrading enzymes in insects, notably B.
mori, that can interfere with the RNAi response (Arimatsu et al.,
2007; Liu et al., 2012). Establishing protocols for consistent RNAi
induction by feeding in different species may, therefore, prove
challenging. In addition, oral delivery of RNAi molecules in species
where systemic RNAi cannot be achieved limits its application to
genes expressed in gut cells (Fig. 2).
A minority of studies have exploited alternative routes for
dsRNA delivery, including electroporation, soaking or ectopic
application, incorporation into nanoparticles, expression in bacteria, topical application, injection into woody plants, direct absorption of dsRNA in water solution into plant cuttings, or rooted
seedlings and trees and solubilization using transfection agents,
such as Lipofectamine™ (Wang et al., 2011; Karim et al., 2010;
Zhang et al., 2010; Pridgeon et al., 2008; Lopez-Martinez et al.,
2012; Hunter et al., 2012). For additional consideration of this topic, the reader is referred to Yu et al. (2013), which provides a comprehensive review of the history and current practice.
3.3. RNAi dosage
The requisite dose of RNAi molecules varies with insect species,
life stage, the target gene transcript abundance and its spatial and
temporal expression proﬁles, and according to the delivery method
of choice. The viscosity of high dsRNA concentrations limits the
injectable concentrations to 6 lg ll1 (K. Michel, unpub data),
and the cost of synthesizing large amounts of dsRNA presents a
challenge for high concentrations in artiﬁcial diets. Species- and
tissue-speciﬁc biological factors, including the degradation of
dsRNA, and weak activity of the RNAi machinery, can inﬂuence
the efﬁcacy of RNAi, often requiring relatively high dosage of RNAi
molecules. There is now persuasive evidence for dsRNase activity
in various extracellular ﬂuids of insects, including the digestive
juices of B. mori (Arimatsu et al., 2007), the saliva of the hemipteran Linus lineolaris (Allen and Walker, 2012) and the hemolymph of
M. sexta (Garbutt et al., 2013). Although, to our knowledge, this has
not been reported in insects, the difﬁculties in achieving RNAi of
genes expressed in neurons of the nematode C. elegans has been
attributed to the high expression of a nuclease (eri-1, enhanced
RNAi-1) in these cells (Kennedy et al., 2004).
The mode of uptake, ability to spread RNAi molecules and ability to process the RNAi molecules are other important considerations that no doubt strongly inﬂuences the requisite dose
required to induce a RNAi response. In D. melanogaster larvae, cell
autonomous RNAi can be induced readily by the expression of
short hairpin RNAs from a transgene; however, injected dsRNAs
fail to trigger RNAi in most tissues with the exception of hemocytes
(Miller et al., 2008). A higher dose is usually required when the
RNA molecule is delivered orally as compared to injection. Multiple
introductions of dsRNA can enhance the efﬁcacy of RNAi in the salivary glands of Rhodnius prolixus (Araujo et al., 2006), and although
the basis for this effect is not fully understood, one attractive
hypothesis is that elements of the RNAi machinery may be expressed at low levels in some tissues (Chintapalli et al., 2007;
Rinkevich and Scott, 2013), but can be induced in response to the
RNAi molecule (Garbutt and Reynolds, 2012; Liu et al., 2013). Pertinently, Ae. aegypti, mounts an antiviral RNAi response to Sindbis
virus infection, but transcript levels for Dicer and Argonaute do not
change appreciably; only Tudor staphylococcal nuclease, an element of the RISC, shows moderate increase in transcript abundance during an active RNAi response (Campbell et al., 2008).

Further research is required to establish the incidence and signiﬁcance of inducibility in RNAi function.
3.4. Choice of gene: transcript abundance and protein stability
In principle, the ideal gene target for RNAi produces an mRNA
pool with high turnover that codes for a protein with a short
half-life. The use of RNAi for phenotypic analysis of gene function
in any life stage could be more difﬁcult if the protein product of
the target gene has a long half-life. For example, nicotinic acetylcholine receptors (nAChRs) can be stable for >2 weeks (Lomazzo
et al., 2011) and this protein stability may explain the weak phenotypic response associated with RNAi-mediated knockdown of Da6
(nicotinic acetylcholine receptor subunit) expression in both D.
melanogaster and T. castaneum (Rinkevich and Scott, 2013). However, for the great majority of genes, mRNA turnover and protein
half-life are not known. This gap in our knowledge presents a major challenge for RNAi experiments.
3.5. Evaluation of RNAi experiments
The desired result of an RNAi experiment varies with the purpose of the study. High insect mortality is a successful outcome
for investigations designed to identify novel RNAi-based strategies
to control an insect pest, but a hindrance to many experimental
investigations of gene function. For many analyses of gene function, physiological indices of predicted function should be central
to the analysis. For example, if a gene under study has a predicted
role in protein digestion, osmoregulation or olfaction, then analyses of gut protease activity, hemolymph osmotic pressure and electroantennogram data, respectively, may be useful physiological
indices. For some experiments, it may be necessary to reduce the
RNAi dose to obtain a reliable physiological signal of gene function
obtained by an intermediate expression knockdown, because
strong knockdown could result in secondary, deleterious effects
on insect ﬁtness that obscure the primary lesion. It is, therefore,
important to deﬁne the appropriate physiological and ﬁtness assays as an integral part of the experimental design.
The successful reduction of transcript levels as a result of RNAi
is most commonly measured by RT-qPCR and expressed as a percent reduction of the relevant transcript in the treatment group
versus the negative control group (in which animals were subjected to an RNAi molecule for a heterologous gene). Although this
methodology is widely accepted, the choice of reference or housekeeping genes for calculating relative transcript levels is challenging. Even if reference genes for RT-qPCR have been described and
validated on the species level, the expression of a reference gene
may vary with the physiology and the tissue being targeted [e.g.
Ponton et al. (2011) (Drosophila), Scharlaken et al. (2008) (honey
bees), Majerowicz et al. (2011) (Rhodnius)].
Ultimately the phenotypic result of an RNAi experiment hinges
on the reduction of protein levels for the gene of interest, and it is
highly desirable to determine relative protein concentration. The
effect of RNAi on the protein may not be well-correlated to the level of transcript suppression. For example, following dsRNA injection targeting An. gambiae SRPN2, SRPN2 protein is not detectable
by western blot in the hemolymph, but transcript levels remain at
40–60% compared to controls (Michel et al., 2005). Finally, it is possible that RNAi could lead to suppression of transcript (and protein), but not yield a phenotype, particularly where redundancy
is built into a speciﬁc biological function. For example, deletion
of one of the most abundant nAChRs in the insect nervous system
results in ﬂies that are ‘‘normal’’ (Perry et al., 2007). Whether
redundancy will present a limitation for a signiﬁcant number of
other genes remains to be established.
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4. Application of RNAi for the management of insect
populations
The potential of RNAi for the management of pest insects and
protection of domesticated beneﬁcial insects, especially the honey
bee, is widely recognized (Xue et al., 2012). In principle, the sequence used in RNAi can be tailored to any taxonomic scale, from
a single genotype to a family or even order of insects; and the identity of the target sequence can be manipulated at will, enabling the
practitioner to respond rapidly to novel pest taxa or to diminishing
efﬁcacy (due to the evolution of resistance, for example) of one target sequence or combination of sequences. In other words, RNAi
offers exquisite speciﬁcity and ﬂexibility that cannot be matched
by traditional chemical insecticides, biological control by natural
enemies, or plants bearing protein-coding transgenes.

4.1. RNAi and the control of insect pests
Proof of principle for the application of RNAi in insect crop
pest control comes from early studies conducted on the western
corn rootworm, Diabrotica virgifera virgifera (WCRW) (Baum
et al., 2007), and cotton bollworm Helicoverpa armigera (CBW)
(Mao et al., 2007). Baum et al. (2007) fed larval WCRW on 290
dsRNAs, from which they identiﬁed 14 genes that reduced larval
performance, and one of these, vacuolar ATPase subunit A (V-ATPase), was carried forward for detailed analysis. Low concentrations of orally-delivered dsRNA against V-ATPase in artiﬁcial
diet suppressed the corresponding WCRW mRNA. Importantly,
larvae reared on transformed corn plants that express V-ATPase
dsRNA also displayed reduced expression of the V-ATPase gene
and caused much reduced plant root damage (Baum et al.,
2007). In the study of Mao et al. (2007) on CBW, the target gene
was a cytochrome P450, CYP6AE14, which is expressed in the larval midgut and detoxiﬁes gossypol, a secondary metabolite common to cotton plants. When CBW was exposed to either
Arabidopsis thaliana or Nicotiana tobacum expressing CYP6AE14
dsRNA, levels of this transcript in the insect midgut decreased,
larval growth was retarded, and both effects were more dramatic
in the presence of gossypol (Mao et al., 2007). Transgenic cotton
plants expressing CYP6AE14 dsRNA also support drastically retarded growth of the CBW larvae, and suffered less CBW damage
than control plants (Mao et al., 2011). The research on both
WCRW and CBW has been extended to additional genes. The
Snf7 gene, which is involved in trafﬁcking of membrane receptors, has been reported to be effective against both D. v. virgifera
and D. v. howardi larvae (Bolognesi et al., 2012; Ramaseshadri
et al., 2013); and cotton plants engineered to express cysteine
proteases attenuated the peritrophic matrix of CBW, resulting
in increased uptake of the dsRNA (Mao et al., 2013). Importantly,
cotton plants expressing both the dsCYP6AE14 and cysteine protease were more protected from bollworm than either of the single-transgene lines (Mao et al., 2013).
The studies of Baum et al. (2007) and Mao et al. (2007) illustrate
two key issues for successful RNAi of insect crop pests: choice of
the target sequence(s) for RNAi; and mode of delivery. The target
gene must be an essential insect gene that is consistently expressed through the relevant life-stages and yields reliable RNAiinduced depression of insect performance. As the technology
moves from proof of principle to application, very careful consideration of the design of the target sequence(s) is required. The prerequisites for success are perfect sequence identity between at
least some of the 21–25 bp siRNAs derived from the dsRNA and
the cognate mRNA of the insect pests; and sufﬁcient sequence
divergence between all the siRNAs and protein-coding genes of
non-target organisms. These analyses can be conducted in silico,
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by comparing a 21–25 bp moving window along the candidate
dsRNA sequence to both the target gene in all target insect taxa,
and to all predicted protein-coding genes in all other publiclyavailable genomes. It may be appropriate to obtain genomic or
transcriptomic data for other non-target taxa that currently lack
genomic resources, so that the in silico analysis of the proposed
dsRNA sequences includes ecologically-relevant organisms. Any
proposed dsRNA that fails to yield multiple siRNAs with perfect
match to the sequence in all pest insects, or that yields a single siRNA that matches the sequence in any relevant non-target organism
should be discarded. Less certain is the degree of sequence mismatch between dsRNA-derived siRNAs and a non-target organism
that can be tolerated. Because siRNA molecules can inhibit translation of transcripts with less than perfect sequence identity, the
threshold for concern about non-target effects could be less than
100% sequence identity. Further work is required to determine
the relative amount of mismatch between the target and effector
that causes lack of efﬁcacy. Such results would inform our understanding of how to optimize pest management while minimizing
effects to non-target organisms and slowing the evolution of resistance (Section 4.3).
The second issue important for the success of RNAi is delivery
at an effective dose, while maintaining acceptable production
costs. Recent breakthroughs in dsRNA production methods,
which can produce kilogram quantities, continues to reduce
the cost associated with dsRNA production and makes it feasible
to start discussing strategies which will apply dsRNA products as
baits, sprays, or through irrigation systems (Hunter et al., 2010,
2012). In planta RNAi has great potential not only against chewing insect pests [such as the WCRW and CBW studied by Baum
et al. (2007) and Mao et al. (2007)], but also against plant sap
feeding pests. Transgenic technologies involving expression of
toxins from Bacillus thuringiensis (Bt) in crop plants have, contributed little to the control of sucking insect pests, because Bt
endotoxins have yet to be identiﬁed with activity against these
pests (Li et al., 2011). In addition, these insects are becoming
increasingly prevalent in Bt crops, as a result of ecological release due to reduced use of broad-spectrum insecticide treatments previously used to control lepidopteran and coleopteran
pests (Faria et al., 2007; Lu et al., 2010). Pyramiding RNAi technologies against sap feeders with Bt (or other technologies)
against chewing insects could resolve these difﬁculties. The
experimental demonstrations of in planta RNAi against the rice
plant hopper Nilaparvata lugens (Zha et al., 2011) and the aphid
Myzus persicae (Pitino et al., 2011) provide a proof of principle
for this technology.
Alternative approaches are being developed for RNAi delivery as
a conventional pesticide, for example as insecticidal baits for urban
pests, such as ants, cockroaches and termites (Zhou et al., 2008), or
for the aquatic larval stages of mosquitoes (see below). The commercial potential of these methods depends critically on the ability
to deliver dsRNA to the target insect, which is in part determined
by stability of the dsRNA in the environment, its concentration in
the baits and take-up rates by the insects, as offset against the production costs for dsRNA. These objectives will be facilitated by formulations that enhance the uptake of dsRNA into insect cells and
its protection against insect dsRNases. For example, dsRNA forms
stable 100–400 nm particles in association with chitosan, through
the electrostatic forces between the positive charges of the amino
group in chitosan and the negatively-charged RNA (McCarroll and
Kavallaris, 2012). Zhang et al. (2010) used the chitosan nanoparticle-based RNAi technology to suppress the expression of two chitin
synthase genes (AgCHS1 and AgCHS2) in African malaria mosquito
(An. gambiae) larvae. Although this treatment did not kill the larvae, it did reduce the larval chitin content and increased larval susceptibility to the insecticide diﬂubenzuron.
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4.2. RNAi and the protection of insects against parasites and pathogens
The susceptibility of many eukaryotic parasites to RNAi offers a
novel strategy to enhance the health of beneﬁcial insects. Of
course, this strategy does not apply to bacterial pathogens or the
various eukaryotes (e.g. trypanosomes and Plasmodium species)
which lack any known capacity for RNAi. The opportunity is vividly
illustrated by the microsporidian parasite Nosema of the honey
bee. Nosema causes high morbidity and mortality of honey bees
(Martin-Hernandez et al., 2011). Two aspects of the biology of Nosema make it an especially suitable target for RNAi-based strategies: it has the molecular machinery for RNAi, and it colonizes
midgut epithelial cells, a site readily accessed by ingested dsRNA.
When fed honey infected with N. ceranae plus dsRNA speciﬁc to
the Nosema ADP/ATP transporter gene, which is essential for Nosema energy metabolism, honey bees had a reduced Nosema load and
lower mortality, together with suppressed transcript abundance of
the target genes (Paldi et al., 2010).
Eukaryotic parasites that exploit insect organs other than the
gut would be susceptible to RNAi only where the insect host displays systemic spread of the RNAi signal. This has been demonstrated for the ectoparasitic mite, Varroa destructor, which feeds
on the blood of honey bees (Garbian et al., 2012). When bees were
fed on dsRNA speciﬁc to a panel of Varroa genes, the density of Varroa mites on the bees was reduced by up to 50%, with no apparent
deleterious effect on the honey bees. The pattern of spread of the
RNAi was tested by allowing honey bees to feed on sucrose solution containing dsRNA-GFP (green ﬂuorescent protein; because
the genomes of both the insect and mite lack the GFP gene, the distribution of GFP-RNA could be monitored without interference
from sequence of endogenous origin). When Varroa-infested bees
were fed on the test solution, the GFP-RNA was recovered in the
Varroa. Moreover, when these Varroa were subsequently transferred to bees feeding on sugar solution without dsRNA-GFP, the
recipient bees acquired the GFP-RNA. These experiments demonstrate that the RNAi can be ampliﬁed and spread not only at the level of the individual insect, but also at the colony level in honey
bees. Further research is required to establish the frequency and
dose of RNAi applications required to sustain protection of colonies, and whether this approach offers a cost-effective strategy
for the control of Varroa mite, which is of ﬁrst-order importance
in compromising the health of honey bee colonies.
RNAi also holds potential to clear insect vector species from
parasites, that themselves are not susceptible to RNAi. A prime
example is parasites of the genus Plasmodium, the causative agent
of malaria (Baum et al., 2009). Conceptually, depletion of proteins
required for parasite entry or survival within the insect vector by
means of RNAi could be used to create refractory mosquitoes
(Brown and Catteruccia, 2006). Proof-of-principle successes have
been achieved in the laboratory (Dong et al., 2011). Effective RNAi
delivery methodologies that are ﬁeld-deployable involve oral
exposure or transgenic population replacement strategies, and
are currently under development.
The natural function of RNAi is protection against viruses, and
RNAi has enormous potential in anti-viral therapy. There are
opportunities for RNAi-mediated suppression of viral infections
in insects, including vectors of socio-economically important viral
diseases of humans, livestock and crop plants. Exogenously-applied or ingested dsRNA can be considered as a boost to the native
RNAi machinery of the host, conferring protection both by prophylaxis and direct treatment. The value of such boosting is illustrated
by research on the titer of various mosquito-vectored arboviruses.
RNAi-mediated antiviral immunity contributes to the suppression
of viruses, including dengue virus and Sindbis virus, in the mosquito Ae. aegypti, as demonstrated by the increased titer and transmission of these viruses in mosquitoes in which the RNAi

machinery was experimentally silenced (Franz et al., 2006; Campbell et al., 2008; Khoo et al., 2010). Furthermore, viral suppression
is promoted by enhancing the RNAi pathway, achieved by engineering the insects to express an inverted-repeat RNA that triggers
production of dsRNA speciﬁc to the virus sequence (Franz et al.,
2011; Mathur et al., 2010). There is some evidence for viral-mediated suppression of RNAi, for example by the Sindbis virus and
West Nile virus, in mosquito cells (Cirimotich et al., 2009; Schnettler et al., 2012). Such suppression may be the reason why supplementary dsRNA is required to achieve RNAi-mediated elimination
of viral infection from the insect host.
Another insect system demanding urgent solutions to viral
infections is the honey bee, especially in the context of evidence
that viruses, including the Israeli acute paralysis virus (IAPV),
may contribute to the ongoing decline of honey bees, including colony collapse disorder (Evans and Schwarz, 2011). Evidence that
exogenous dsRNA can supplement the endogenous RNAi machinery comes from the demonstration that IAPV infection of honey
bees can be eliminated by orally-delivered dsRNA corresponding
to two different sequences of the IAPV genome (Maori et al.,
2009). Among colonies inoculated with IAPV, mortality was reduced in those treated with IAPV-dsRNA relative to those that were
not treated or that were treated with non-IAPV dsRNA. These results led to large-scale ﬁeld test in the USA, in which honey bees
were fed a dsRNA product, Remebee-I, in the presence of the IAPV
(Hunter et al., 2010). Honey bee survival, colony size and honey
production were all increased in the Remebee-I treatment. Ingested IAPV-speciﬁc dsRNA successfully reduced the negative effects of IAPV infection in 160 honey bee hives in two states
(Florida and Pennsylvania) with very different climates and seasons. These results provide the ﬁrst successful ﬁeld demonstration
of the use of RNAi as a large scale preventative treatment for an insect disease.
The antiviral effect of RNAi has also been successfully augmented for disease control in a non-insect arthropod, the cultured
shrimp, L. vannamei. Diseases caused by viruses are economically
devastating to the shrimp industry, and induced RNAi provides
protection from a number of different viruses, including singleand double-stranded RNA viruses and a DNA virus (Bartholomay
et al., 2012). This strategy enhances RNAi-based antiviral immunity, providing long-term, highly speciﬁc protection and a route
for vaccination of cultured shrimp against viral diseases. For example, dsRNA designed to target the 50 end of ORF1 in the genome of
Infectious myonecrosis virus (IMNV) provides signiﬁcant disease
protection even 52 days after vaccination (Loy et al., 2012). More
recently, the same RNAi trigger was used to provide therapeutic effect such that disease pathology resolved and 50% of animals survived if the RNAi trigger was provided within 48 h post-infection
(Loy et al., 2012). The outstanding challenge is a viable delivery
strategy, because shrimp culture involves hundreds of thousands
of animals in hectare-sized ponds.
4.3. The evolutionary stability of RNAi-based management of insect
populations
The relationship between viruses and RNAi-based insect immunity is evolutionarily dynamic. This is indicated by both the presence of viral suppressors of RNAi (see above) and the positive
selection on the genes contributing to RNAi-machinery interacting
with siRNAs, but not the endogenous miRNAs (Obbard et al., 2006).
We can, therefore, anticipate that insects, viruses and eukaryotic
parasites will respond to strong selection exerted by RNAi-based
control strategies. For example, insects that carry viruses with
RNAi suppressors would be at a selective advantage on RNAi-protected crops, and RNAi-based prophylactics for honey bee colonies
would select for viral pathogens with RNAi suppression. The RNAi
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suppression mechanisms that have evolved are not speciﬁc to a
particular target sequence. This implies that resistance to a dsRNA
speciﬁc to one gene cannot be prevented by pyramiding multiple
genes with different function, nor overcome by switching to a different gene or gene set.
The genetic variation that exists within and among insect populations could also present a challenge to the application of RNAi
for pest control, depending on the amount of mismatch present between the dsRNA and the target transcript. Furthermore, single
nucleotide polymorphisms (SNPs) that result in lower effectiveness
of the RNAi, could potentially be selected for and lead to the evolution of resistance. If such SNPs were synonymous they would
be expected to have little or no ﬁtness cost in the absence of the
selecting agent (dsRNA), and resistance could evolve rapidly. However, the degree of mismatch (i.e. the number of SNPs) that would
be needed to prevent RNAi from controlling a pest is not known.
The long-term beneﬁts of RNAi-based applications in insect pest
management will require new and independent thought on effective resistance management strategies designed to minimize selective pressures and delay the evolution of resistance.
4.4. RNAi risks and regulation
The above examples offer clear evidence for potential applications for RNAi for the control of insect pests, manipulation of insect
disease vectors, and management of beneﬁcial insects, together
with concerns about the stability of RNAi strategies in the face of
selection for resistance. Overlying these considerations is a very
real uncertainty regarding the environmental and ecological risks
posed by these technologies. The Federal regulatory framework
for estimating the ecological risks associated with RNAi technologies is still in development, and a number of critical gaps remain
including potential toxicity to non-target organisms (see Section 4.1), environmental fate, and importantly, the risk of resistance evolution in target pests (Section 4.3). Documenting
efﬁcacy of the technology is ongoing and regulatory considerations
for RNAi-based insecticidal traits, such as the development of standardized environmental risk assessment, are still being developed
(Auer and Frederick, 2009; http://cera-gmc.org/docs/cera_publications/pub_08_2011.pdf). Considerations of how to evaluate
sequence speciﬁcity, environmental fate, and exposure of nontarget organisms are still being developed. However, US regulatory
agencies such as the Environmental Protection Agency and the
Department of Agriculture have provided preliminary assessments
(http://cera-gmc.org/docs/cera_publications/pub_08_2011.pdf)
suggesting that data requirements for RNAi traits may be reduced
based primarily on the lack of a plant incorporated protein, such as
a Bt toxin. There is also a lack of information on the risk of insect
resistance to RNAi-mediated control that is a critical impediment
to the development of an insect resistance management plan
aimed at promoting a responsible and sustainable use of the technology. Insecticide resistance presents a major challenge for the
sustainable control of pests. In the case of insects, pest species have
found ways to evolve resistance to nearly every control strategy
that has been used. Predictions that resistance could not develop
to a new control strategy (e.g., Williams, 1967) have proven to be
wrong time and time again.
5. Concluding comments
A decade of research on RNAi in insects has demonstrated the
great power of the technology for discovery-led science and potential for improved management of insect populations. As the science
has matured, it has equally become evident that RNAi is no panacea, but introduces a range of new conceptual and technological
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challenges for insect scientists. Insects vary widely in their amenability to RNAi, and no single protocol is suitable for all species.
Against the backdrop of this functional diversity, it is unfortunate
that there has been a dearth of systematic investigation of the
mechanisms of RNAi in insects. We still have only a weak understanding of whether and how the RNAi signal is ampliﬁed in individual cells and disseminated between cells in insects. It is
increasingly recognized that the caveats in our understanding of
insect-speciﬁc mechanism are a major limitation to the implementation of RNAi. A priority for the future is for the insect research
community to apply their persistence and ingenuity to solve the
fundamentals of how insect RNAi works, in the context of the
physiology of the insect body, and apply that to the pressing problems posed by pests and beneﬁcial insects.
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